This particular statement really bothers me, is CMS now going to take on the role of “doctor here? “ The Bush administration argued that Medicare officials had the right to decide whether the expense incurred for a given item, not just the item itself, was “reasonable and necessary.” How...
Posted to
The Medical Quack .... by Barbara Duck
on 11-04-2008
Filed under: Medically Related, Insurance, My Commentaries, healthcare, Pharma, Congress, CMS, Medicare contractor, Drug costs, Federal Court
The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
on 11-02-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
This actually a pretty good start and I have had my own campaign of sorts going on with getting the FDA up to speed, and they are definitely having to play catch up, as are some other government agencies. In prior posts I had written that some clinical studies were still being written in long hand...
Posted to
The Medical Quack .... by Barbara Duck
on 10-31-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, healthcare, Education, Pharma, FDA, Personal Health Records, GSK, Consumer Healthcare, Drug Interactions
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
on 10-13-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
In other words, this is called Business Intelligence. Lots of it out there to choose from and one from Microsoft specifically related to hospital management and budgets. Before the demise of Wall Street it wasn’t too long ago that I posted about the All Nighter they pulled to mine and try...
Posted to
The Medical Quack .... by Barbara Duck
on 09-26-2008
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, Pharma, Biotech, Cancer, Business Intelligence, R and D, Wall Street, Pricing
One more survey, do we really need to spend this money, I think we have a pretty good idea here that it is not many. My personal opinion here would be to spend the money and enable and educate folks on how this can be done, rather than to see how many can’t, it’s an obvious. If the money...
Medical Quack on Reuters. Now this is a sad state of affairs to be the prudent consumer, and yet you are potentially taking money out of your doctor's pocket by doing so when it comes to pay for performance for them, so what's up with this when purchasing $4.00 Generic Drugs. BD...
Posted to
The Medical Quack .... by Barbara Duck
on 09-18-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, My Commentaries, health insurance, Physicians, Pharma, HMO, Generic Drugs, Pay for Performance, Patients